BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2285451)

  • 1. [Prevalence and epidemiologic features of subjects found to be infected with HIV when donating blood. CTS of the "Retrovirus" Study Group of the Société Nationale de Transfusion Sanguine].
    Couroucé AM; Baudelot J; Elghouzzi MH; Gueguen M; Janot C; Lemaire JM; Maniez M; Mesnier F; Noël L; North ML
    Rev Fr Transfus Hemobiol; 1990 Dec; 33(6):431-8. PubMed ID: 2285451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV seropositivity in blood donations: prevalence, residual risk and epidemiology. The "Retrovirus" Work Group of the French Society of Blood Transfusion].
    Couroucé AM
    Transfus Clin Biol; 1995; 2(5):357-63. PubMed ID: 8581178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV seropositivity among blood donors from 1985 to 1989. CTS du Groupe de Travail Rétrovirus de la Société Nationale de Transfusion Sanguine].
    Couroucé AM; Baudelot J; Elghouzzi MH; Gueguen M; Janot C; Lemaire JM; Maniez M; Mesnier F; Noël L; North ML
    Rev Fr Transfus Hemobiol; 1989 Sep; 32(4):299-305. PubMed ID: 2818772
    [No Abstract]   [Full Text] [Related]  

  • 4. Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group.
    Busch MP; Dodd RY; Lackritz EM; AuBuchon JP; Birkmeyer JD; Petersen LR
    Transfusion; 1997 Oct; 37(10):1003-11. PubMed ID: 9354817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between antibody to hepatitis B core antigen and retroviral infections in blood from volunteer donors.
    Korelitz JJ; Busch MP; Kleinman SH; Williams AE; Zuck TF; Gilcher RO; Ownby HE; Co Chien H; Nemo GJ
    Transfusion; 1996 Mar; 36(3):232-7. PubMed ID: 8604508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiologic study of HIV serology in blood donors from 5 departments in northeastern France (1985-1989)].
    Aymard JP; Janot C; Contal P; Linel C; Monange G; Streiff F
    Rev Fr Transfus Hemobiol; 1989 Dec; 32(6):421-9. PubMed ID: 2629757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HIV seropositivity in blood donors from 1990 to 1992: prevalence, estimation of residual risk of transfusion-related infections and epidemiology].
    Couroucé AM
    Rev Fr Transfus Hemobiol; 1993 Jul; 36(4):327-37. PubMed ID: 8357445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seroprevalence of hepatitis B and C viruses, HIV-1/2 and syphilis among blood donors in the Yaoundé Central Hospital in the centre region of Cameroon].
    Ankouane F; Noah Noah D; Atangana MM; Kamgaing Simo R; Guekam PR; Biwolé Sida M
    Transfus Clin Biol; 2016 May; 23(2):72-7. PubMed ID: 26791918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus infection, hepatitis B virus infection, and sexual behaviour of women attending a genitourinary medicine clinic.
    Evans BA; McCormack SM; Bond RA; MacRae KD; Thorp RW
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):473-5. PubMed ID: 3126866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Occurrence of non-A, non-B post-transfusion hepatitis in heart surgery. Prospective study on the value of the determination of serum alanine aminotransferase and detection of anti-HBc antibodies in blood donors].
    Gayet S; Aymard JP; Janot C; Guillemin C; Briquel ME; Gaucher P; Streiff F
    Rev Fr Transfus Immunohematol; 1986 Dec; 29(6):485-94. PubMed ID: 3108992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
    Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E
    Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can anti-HBc testing decrease the residual risk of transfusion-related HIV transmission?
    Fiedler H
    Vox Sang; 1991; 61(2):144-5. PubMed ID: 1763501
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors and anti-HBc reactivity among first time blood donors.
    Molijn MH; van der Linden JM; Ko LK; Gorgels J; Hop W; van Rhenen DJ
    Vox Sang; 1997; 72(4):207-10. PubMed ID: 9228709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and significance of anti-HBc in the blood bank; preliminary results of a controlled prospective study.
    Katchaki JN; Siem TH; Brouwer R; Brandt KH; van der Waart M
    J Virol Methods; 1980 Dec; 2(1-2):119-25. PubMed ID: 7228974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
    Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
    Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany.
    Houareau C; Offergeld R
    Vox Sang; 2019 Jul; 114(5):459-466. PubMed ID: 30968958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterosexually acquired human immunodeficiency virus infection and the United States blood supply: considerations for screening of potential blood donors. HIV Blood Donor Study Group.
    Petersen LR; Doll LS; White CR; Johnson E; Williams A
    Transfusion; 1993 Jul; 33(7):552-7. PubMed ID: 7687391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis. The EATHIS Eco Research Group. European Acute Transfusion Hepatitis Interferon Study.
    Colin C; Vergnon P; Jullien AM; Excoffier S; Matillon Y; Trepo C
    Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):220-7. PubMed ID: 9131325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.